Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

The 12 Top Biotech Companies Hiring Now
BioSpace
Tue, 05/10/22 - 10:26 pm
Tags:
biotech, life sciences, hirings, Regeneron, Pfizer, Amgen, AbbVie, Moderna Therapeutics, CSL Behring, Waters Corporation, Daiichi Sankyo, Gilead Sciences, Grail, Emergent BioSolutions, resilience
In wake of Biogen's skirmish with the SEC, pharma giants are changing the way they do quarterly reports
Endpoints
Thu, 05/5/22 - 11:34 pm
Tags:
Biogen, earnings, SEC, Eli Lilly, Merck, Bristol Myers Squibb, Pfizer, AbbVie
AbbVie's red-hot Rinvoq scores fourth FDA approval in five months
Fierce Pharma
Sat, 04/30/22 - 02:34 pm
Tags:
AbbVie, Rinvoq, FDA, ankylosing spondylitis
AbbVie's Q1 Good News That Investors Could Be Missing
Motley Fool
Sat, 04/30/22 - 02:31 pm
Tags:
AbbVie, Humira, earnings, Allergan
More molecular glue: Plexium pens AbbVie pact months after Amgen deal
Endpoints
Thu, 04/28/22 - 10:59 am
Tags:
Plexium, molecular glue, AbbVie, targeted protein degradation, neurological disorders
Pharma Continues to Support Ukraine as War Rages On
BioSpace
Fri, 04/22/22 - 10:40 am
Tags:
Russia, Ukraine, AbbVie, Novartis, Pfizer
First-quarter biotech risers work hard for the win
EP Vantage
Thu, 04/21/22 - 10:32 am
Tags:
biotech, AbbVie, Bayer, Ipsen, Lantheus Medical
AbbVie shreds alpha-synuclein Parkinson's pact on cusp of phase 2, thinning field led by Roche
Fierce Biotech
Wed, 04/20/22 - 10:59 am
Tags:
AbbVie, Parkinson's Disease, alpha-synuclein, clinical trials, ABBV-0805
Outside of big pharma, life remains tough for listed developers
EP Vantage
Wed, 04/20/22 - 10:38 am
Tags:
pharma stocks, AbbVie, AstraZeneca, BeiGene, BioNTech, Moderna Therapeutics, Pfizer, Roche
AbbVie takes next step in Ukraine, donating all Russia profits to relief
Endpoints
Tue, 04/19/22 - 11:39 pm
Tags:
AbbVie, Ukraine, Russia
Takeover-driven resurgence fails to materialize for biotech
EP Vantage
Thu, 04/14/22 - 10:41 am
Tags:
M&A, AbbVie, Biocon, Biogen, Biohaven, GSK, Halozyme Therapeutics, Samsung Bioepis, UCB, Viatris
AbbVie preps filings for lymphoma bispecific licensed from Genmab
Pharmaforum
Thu, 04/14/22 - 10:39 am
Tags:
AbbVie, Genmab, cancer, epcoritamab, large B-cell lymphoma
AACR: AbbVie's navitoclax goes after tough blood cancer, not yet reaching overall survival benchmark
Fierce Biotech
Tue, 04/12/22 - 08:31 pm
Tags:
AACR, AbbVie, navitoclax, myelofibrosis, blood cancer
US Congress proposes bills to strengthen pharma competition, promote innovation
BioSpace
Fri, 04/8/22 - 10:49 am
Tags:
congress, legislation, competition, innovation, AbbVie
In a year of big growth for AbbVie, CEO Richard Gonzalez scored $24M pay package
Fierce Pharma
Thu, 03/31/22 - 10:44 am
Tags:
AbbVie, Richard Gonzalez, executive pay, Pharma CEOs
Teva, AbbVie ink opioid settlements worth nearly $330M with Florida
Fierce Pharma
Thu, 03/31/22 - 10:25 am
Tags:
Teva Pharmaceutical, AbbVie, legal, Florida, opioids, opioid crisis
Ahead of Humira's patent cliff, AbbVie's Rinvoq notches third new use in 4 months
Fierce Pharma
Thu, 03/17/22 - 11:33 pm
Tags:
AbbVie, Rinvoq, ulcerative colitis, FDA
Novartis, Eli Lilly and AbbVie join growing list of Big Pharmas severing ties with Russia
Endpoints
Tue, 03/15/22 - 11:36 pm
Tags:
Russia, Ukraine, Novartis, Eli Lilly, AbbVie
AbbVie, eyeing shift to endemic, adds to COVID-19 work with Scripps partnership
Fierce Biotech
Tue, 03/15/22 - 11:33 pm
Tags:
AbbVie, Scripps Research Institute, COVID-19, antivirals
AbbVie doubles down on Gedeon Richter pact that brought Vraylar to the world
Fierce Biotech
Fri, 03/11/22 - 10:40 am
Tags:
AbbVie, Gedeon Richter, Vraylar

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.